Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月

High-Level Dialogue Among Pathology Experts from Across the Taiwan Strait and Four Regions: Patient-Centered Precision Medicine Model

Continue reading
06 2 月

Peeling zongzi for my father while watching football together.

Continue reading
06 2 月

New Antibody // SMARCA4/Brg1—An Independent Predictor of Multi-Tumor Progression and Treatment Efficacy

Continue reading
06 2 月

With Original Aspirations and a Sense of Mission, Mainewell’s “Cloud Annual Meeting” Successfully Concludes.

Continue reading
06 2 月

Fuzhou Maixin Donates 70,350 Yuan to Earthquake-Stricken Areas.

Continue reading
06 2 月

Emergency Consultation During Surgery

Continue reading
06 2 月

Deputy Director Wang Shucai of the Medical Device Regulatory Department of the National Medical Products Administration Visits Maxin for Research

Continue reading
06 2 月

INI-1: A Multi-Tumor Diagnostic and Differentiation Indicator

Continue reading
06 2 月

SSTR2 as an Independent Prognostic Indicator for Neuroendocrine Tumors

Continue reading
06 2 月

What is the Epstein-Barr Virus? What are its risks?

Continue reading
  • «
  • ‹
  • 32
  • 33
  • 34
  • 35
  • 36
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar